These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 19479935)
1. Notch-1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression. Whelan JT; Kellogg A; Shewchuk BM; Hewan-Lowe K; Bertrand FE J Cell Biochem; 2009 Aug; 107(5):992-1001. PubMed ID: 19479935 [TBL] [Abstract][Full Text] [Related]
2. NOTCH and PTEN in prostate cancer. Bertrand FE; McCubrey JA; Angus CW; Nutter JM; Sigounas G Adv Biol Regul; 2014 Sep; 56():51-65. PubMed ID: 24933481 [TBL] [Abstract][Full Text] [Related]
3. CBF-1 (RBP-J kappa) binds to the PTEN promoter and regulates PTEN gene expression. Whelan JT; Forbes SL; Bertrand FE Cell Cycle; 2007 Jan; 6(1):80-4. PubMed ID: 17245125 [TBL] [Abstract][Full Text] [Related]
4. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model. Kwon OJ; Zhang L; Wang J; Su Q; Feng Q; Zhang XH; Mani SA; Paulter R; Creighton CJ; Ittmann MM; Xin L J Clin Invest; 2016 Jul; 126(7):2626-41. PubMed ID: 27294523 [TBL] [Abstract][Full Text] [Related]
5. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways. Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963 [TBL] [Abstract][Full Text] [Related]
6. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465 [TBL] [Abstract][Full Text] [Related]
7. SLUG is a direct transcriptional repressor of PTEN tumor suppressor. Uygur B; Abramo K; Leikina E; Vary C; Liaw L; Wu WS Prostate; 2015 Jun; 75(9):907-16. PubMed ID: 25728608 [TBL] [Abstract][Full Text] [Related]
8. Increased protein expression of the PTEN tumor suppressor in the presence of constitutively active Notch-1. Chappell WH; Green TD; Spengeman JD; McCubrey JA; Akula SM; Bertrand FE Cell Cycle; 2005 Oct; 4(10):1389-95. PubMed ID: 16096376 [TBL] [Abstract][Full Text] [Related]
9. Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer. Su Q; Zhang B; Zhang L; Dang T; Rowley D; Ittmann M; Xin L Oncogene; 2017 Feb; 36(5):618-627. PubMed ID: 27345403 [TBL] [Abstract][Full Text] [Related]
12. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence. Manda KR; Tripathi P; Hsi AC; Ning J; Ruzinova MB; Liapis H; Bailey M; Zhang H; Maher CA; Humphrey PA; Andriole GL; Ding L; You Z; Chen F Oncogene; 2016 Jun; 35(25):3282-92. PubMed ID: 26477312 [TBL] [Abstract][Full Text] [Related]
13. Loss of the Notch effector RBPJ promotes tumorigenesis. Kulic I; Robertson G; Chang L; Baker JH; Lockwood WW; Mok W; Fuller M; Fournier M; Wong N; Chou V; Robinson MD; Chun HJ; Gilks B; Kempkes B; Thomson TA; Hirst M; Minchinton AI; Lam WL; Jones S; Marra M; Karsan A J Exp Med; 2015 Jan; 212(1):37-52. PubMed ID: 25512468 [TBL] [Abstract][Full Text] [Related]
14. Activation of nuclear PTEN by inhibition of Notch signaling induces G2/M cell cycle arrest in gastric cancer. Kim SJ; Lee HW; Baek JH; Cho YH; Kang HG; Jeong JS; Song J; Park HS; Chun KH Oncogene; 2016 Jan; 35(2):251-60. PubMed ID: 25823029 [TBL] [Abstract][Full Text] [Related]
15. Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism. Wu X; Xu K; Zhang L; Deng Y; Lee P; Shapiro E; Monaco M; Makarenkova HP; Li J; Lepor H; Grishina I Dev Biol; 2011 Aug; 356(2):337-49. PubMed ID: 21624358 [TBL] [Abstract][Full Text] [Related]
16. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088 [TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions. Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263 [TBL] [Abstract][Full Text] [Related]
18. Prostate tumorigenesis induced by PTEN deletion involves estrogen receptor β repression. Mak P; Li J; Samanta S; Chang C; Jerry DJ; Davis RJ; Leav I; Mercurio AM Cell Rep; 2015 Mar; 10(12):1982-91. PubMed ID: 25818291 [TBL] [Abstract][Full Text] [Related]
19. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163 [TBL] [Abstract][Full Text] [Related]
20. Expression of PTEN in malignant and non-malignant human prostate tissues: comparison with p27 protein expression. Fenic I; Franke F; Failing K; Steger K; Woenckhaus J J Pathol; 2004 May; 203(1):559-66. PubMed ID: 15095479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]